November 2, 2021 -- Biotech company EdiGene has signed a lease for 14,000 sq ft of lab and office space for its U.S. R&D center in the greater Boston area.
The center will work to translate EdiGene's gene editing technologies into new therapies for serious genetic diseases and cancer, according to the vendor.